Related Experiment Video

Updated: Aug 14, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

[The efficacy of using low doses of immunomodulators for treating experimental tumors]

S A Shalimov, G P Potebnia, G S Lisovenko

    Klinichna Khirurhiia
    |September 14, 1999
    PubMed

    Insights

    Small doses of antitumoral vaccines demonstrated significant tumor growth inhibition in experiments. This research highlights the potential of immunomodulating agents in cancer chemotherapy, particularly super-low doses.

    Area of Science:

    • Oncology
    • Immunology
    • Pharmacology

    Background:

    • Research explores the biological effects of various substances, focusing on low-dose antitumoral chemopreparations.
    • Investigates the efficacy of immunomodulating agents in cancer chemotherapy.

    Purpose of the Study:

    • To evaluate the efficacy of different doses of immunomodulating agents, including arbisol, nucleoplat, Yersinia enterocolitica substrate, and an antitumoral vaccine.
    • To assess the impact of these agents on tumor growth in experimental settings.

    Main Methods:

    • Experimental administration of various immunomodulating agents at different dosages.
    • Monitoring and statistical analysis of tumor growth inhibition in response to treatments.

    Main Results:

    • Super-low doses of an antitumoral vaccine resulted in statistically significant inhibition of tumoral growth.
    • The study presents data on the efficacy of various doses of immunomodulating agents.

    Conclusions:

    • Super-low dose antitumoral vaccines show promise for cancer chemotherapy.
    • Immunomodulating agents, particularly at reduced doses, warrant further investigation for their therapeutic potential in oncology.

    More Related Videos

    Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice07:36

    Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

    Published on: June 12, 2021

    Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

    Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

    Published on: February 24, 2023

    Related Concept Videos

    Tumor Immunotherapy01:27

    Tumor Immunotherapy

    Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
    Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

    Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

    Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...